Skip to content

Studying Biomarkers in Samples From Young Patients With Rhabdoid Tumors

Endogenous DNA Transposition in Rhabdoid Tumors

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01544569
Enrollment
50
Registered
2012-03-06
Start date
2012-03-31
Completion date
Unknown
Last updated
2016-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney Cancer

Keywords

rhabdoid tumor of the kidney

Brief summary

RATIONALE: Studying samples of tissue from patients with rhabdoid tumors in the laboratory may help doctor learn more about changes that occur in DNA and identify genes related to cancer. PURPOSE: This research trial studies biomarkers in samples from young patients with rhabdoid tumors.

Detailed description

OBJECTIVES: * To investigate the expression and function of transposons in 50 primary rhabdoid tumors. OUTLINE: Freshly frozen rhabdoid tumors will be studied using fluorescence in situ hybridization (FISH) and polymerase chain reaction (PCR) to establish the genomic location of transposons. Protein expression in rhabdoid tumor tissue microarrays is also analyzed.

Interventions

GENETICDNA analysis
GENETICfluorescence in situ hybridization
GENETICgene expression analysis
GENETICmicroarray analysis
GENETICpolymerase chain reaction
GENETICprotein expression analysis
OTHERlaboratory biomarker analysis
OTHERmedical chart review

Sponsors

National Cancer Institute (NCI)
CollaboratorNIH
Children's Oncology Group
Lead SponsorNETWORK

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 1 Years
Healthy volunteers
No

Inclusion criteria

DISEASE CHARACTERISTICS: * Freshly frozen rhabdoid tumors from either renal or extra-renal sites from children younger than 2 years of age * Clinical patient information (age, gender, comorbidities, tumor stage, size, pathology, therapy, outcome) available PATIENT CHARACTERISTICS: * Not specified PRIOR CONCURRENT THERAPY: * Not specified

Design outcomes

Primary

MeasureTime frame
Expression and function of transposons in rhabdoid tumors

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026